<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Contrarian Stock Market Investing News - Featuring Bargain Stocks &#187; ALO</title>
	<atom:link href="http://www.contrarianprofits.com/articles/tag/alo/feed" rel="self" type="application/rss+xml" />
	<link>http://www.contrarianprofits.com</link>
	<description>Access market-beating ideas from the world&#039;s top investment gurus on stock market investing, the gold market, ETFs, Forex trading and real estate values.</description>
	<lastBuildDate>Tue, 24 Nov 2009 15:03:47 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Europe Stocks Rise as Buoyant Pharmas Offset Miners</title>
		<link>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311</link>
		<comments>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311#comments</comments>
		<pubDate>Fri, 28 Nov 2008 19:54:20 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[ALO]]></category>
		<category><![CDATA[BMW]]></category>
		<category><![CDATA[BP]]></category>
		<category><![CDATA[deflation]]></category>
		<category><![CDATA[Energy Firms]]></category>
		<category><![CDATA[Europe Stocks]]></category>
		<category><![CDATA[European Shares]]></category>
		<category><![CDATA[European Stocks]]></category>
		<category><![CDATA[FP]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Industrial Sectors]]></category>
		<category><![CDATA[Market Rally]]></category>
		<category><![CDATA[mining stocks]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[pharma stocks]]></category>
		<category><![CDATA[Pharmaceuticals Industry]]></category>
		<category><![CDATA[RNO]]></category>
		<category><![CDATA[SI]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[VLKAY]]></category>
		<category><![CDATA[XTA]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=9311</guid>
		<description><![CDATA[<p>FTSEurofirst 300 up 1.1 pct on the day, up 13 pct on week&#8230; Index lost 7 pct in Nov, ninth month of losses in 2008&#8230; Cyclicals hammered; defensive pharmas surge </p>
<p> </p>
<p> European stocks ended higher on Friday, as buoyant pharmaceutical shares eclipsed a drop in cyclical mining and industrial sectors hit by renewed economic fears, while energy shares tumbled along with oil. </p>
<p> The FTSEurofirst 300 index of top European shares  closed 1.1 percent higher at 862.07 points. </p>
<p> Although it gained 13 percent during the week, the index dropped 7 percent in November, recording a ninth month of losses in what has been a torrid 2008 for equities worldwide. </p>
<p> Pharma stocks made strong gains on Friday, with  <a href="http://finance.google.com/finance?q=LON:GSK">GlaxoSmithKline</a> up 5.1 percent and <a href="http://finance.google.com/finance?q=NYSE:SNY">Sanofi-Aventis</a> up&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>FTSEurofirst 300 up 1.1 pct on the day, up 13 pct on week&#8230; Index lost 7 pct in Nov, ninth month of losses in 2008&#8230; Cyclicals hammered; defensive pharmas surge </p>
<p> </p>
<p> European stocks ended higher on Friday, as buoyant pharmaceutical shares eclipsed a drop in cyclical mining and industrial sectors hit by renewed economic fears, while energy shares tumbled along with oil. </p>
<p> The FTSEurofirst 300 index of top European shares  closed 1.1 percent higher at 862.07 points. </p>
<p> Although it gained 13 percent during the week, the index dropped 7 percent in November, recording a ninth month of losses in what has been a torrid 2008 for equities worldwide. </p>
<p> Pharma stocks made strong gains on Friday, with  <a href="http://finance.google.com/finance?q=LON:GSK">GlaxoSmithKline</a> up 5.1 percent and <a href="http://finance.google.com/finance?q=NYSE:SNY">Sanofi-Aventis</a> up 4.5 percent. <a href="http://finance.google.com/finance?q=NYSE:NVS">Novartis </a>, whose CEO said the company could increase its dividend and also resume share buybacks once it has reduced its debt, gained 4.4 percent. </p>
<p> The sector rallied after the publication of a long-anticipated EU report on generic competition. Although Competition Commissioner Neelie Kroes said preliminary results showed competition in the pharmaceuticals industry &#8220;does not work as well as it should&#8221;, traders said the absence of specific penalties in the report brought some relief to pharma stocks. </p>
<p> Energy firms such as <a href="http://finance.google.com/finance?q=EPA:FP">Total </a>and <a href="http://finance.google.com/finance?q=BP+">BP </a>dropped  0.7-2.6 percent as oil prices  sank below $52 a barrel on  signs OPEC would defer cutting production when it meets this  weekend in Cairo. </p>
<p> Industrials were also among the biggest losers, with <a href="http://finance.google.com/finance?q=NYSE:SI">Siemens </a>down 3.8 percent and <a href="http://finance.google.com/finance?q=Alstom+">Alstom </a>down 6 percent. </p>
<p> Despite the market&#8217;s recovery during the week, analysts  remain wary about a potential &#8220;Christmas rally&#8221; this year. </p>
<p> &#8220;The volatility is not about to come down immediately. The economic newsflow is just too horrible. It&#8217;s too early to call for a straight market rally at this point,&#8221; said Arthur van Slooten, strategist at Societe Generale, in Paris. </p>
<p> &#8220;With deflation fears, risky assets have been pricing in the worst. But it doesn&#8217;t mean that all of a sudden, from now on you have a straight way up. We know that the newsflow will be terrible, but we need at least some sort of indication that the bottom is maybe in sight,&#8221; he said. </p>
<p> &#8220;Next year&#8217;s first quarter will really look awful in terms of macro data and with analyst further downgrading their estimates and companies finally becoming realistic in their own guidance. That in itself could provide us with a sound basis to build from there.&#8221; </p>
<p> Miners took a beating on Friday, adding to recent sharp  losses. <a href="http://finance.google.com/finance?q=LON:AAL">Anglo American</a> shed 2.4 percent and <a href="http://finance.google.com/finance?q=Xstrata+">Xstrata </a>dropped 3 percent. </p>
<p> Prices for copper, a key industrial metal, slipped as tumbling industrial production data from Japan highlighted bleak prospects for demand in an oversupplied market, while prices for aluminium also fell, hit by the rising fears about the health of the embattled auto sector. </p>
<p> &#8220;There is little doubt that the outlook for metals demand is grim for at least the next few quarters and prices have fallen to levels that reflect market expectations for further stock increases,&#8221; Barclays Capital said in a note. </p>
<p> Automakers lost ground, with <a href="http://finance.google.com/finance?q=OTC%3AVLKAY">Volkswagen </a>down 5  percent, BMW  off 3.4 percent and <a href="http://finance.google.com/finance?q=EPA%3ARNO">Renault </a>down 4.8 percent. </p>
<p> &#8220;Going into the weekend, one can&#8217;t help but worry that we are only a heartbeat away from the next scare story,&#8221; said Chris Hossain, senior sales manager at ODL Securities. </p>
<p> &#8220;The markets appear to have been buoyed by the feeling that the U.S. will be bailing out the auto industry, but one has to wonder how much more the global governments can continue to support troubled industries,&#8221; he added. </p>
<p> Around Europe, Germany&#8217;s DAX index eked out a gain of 0.1 percent, UK&#8217;s FTSE 100 index rose 1.5 percent and France&#8217;s CAC 40 added 0.4 percent. </p>
<p>By Blaise Robinson<br />
PARIS, Nov 28 (Reuters)</p>
]]></content:encoded>
			<wfw:commentRss>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global Investing Roundups, Tuesday, November 25th, 2008</title>
		<link>http://www.contrarianprofits.com/articles/global-investing-roundups-tuesday-november-25th-2008/9064</link>
		<comments>http://www.contrarianprofits.com/articles/global-investing-roundups-tuesday-november-25th-2008/9064#comments</comments>
		<pubDate>Tue, 25 Nov 2008 15:41:04 +0000</pubDate>
		<dc:creator>William Patalon III</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[ALO]]></category>
		<category><![CDATA[Alpharma Inc]]></category>
		<category><![CDATA[alternative energies]]></category>
		<category><![CDATA[Banco Santander]]></category>
		<category><![CDATA[CEO]]></category>
		<category><![CDATA[Chilean Economy]]></category>
		<category><![CDATA[China Oil]]></category>
		<category><![CDATA[Cnooc Ltd]]></category>
		<category><![CDATA[Crude Oil Prices]]></category>
		<category><![CDATA[Existing Home Sales]]></category>
		<category><![CDATA[KG]]></category>
		<category><![CDATA[King Pharmaceuticals Inc]]></category>
		<category><![CDATA[Solar Electric Power]]></category>
		<category><![CDATA[SPWRA]]></category>
		<category><![CDATA[Sunpower Corp]]></category>
		<category><![CDATA[US Jobless Rate]]></category>
		<category><![CDATA[William Patalon III]]></category>
		<category><![CDATA[XRX]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=9064</guid>
		<description><![CDATA[<p>Existing Home Sales Down 3.1%; Chile’s 3Q GDP Beat Forecast; SunPower Finishes 18-Megawatt Plant; Cnooc Pushing to Develop More Oil Sites; Alpharma Gets Kinged; Xerox On Track; Oil Jumps 9%; </p>
<ul type="disc">
<li>Sales       of existing homes fell 3.1% in October, <a href="http://www.reuters.com/article/newsOne/idUSTRE4AN45720081124" target="_blank">the       lowest drop in four years</a>, <strong><em>Reuters</em></strong> reported. Over the past year, medium home prices also declined 11.3% to $183,300, the biggest percentage drop since the National Association of Realtors began keeping records in 1968.</li>
</ul>
<ul type="disc">
<li>Chile’s gross domestic product beat forecasts and grew 4.8% in the third quarter. Domestic demand was strong, as was energy output. “These figures surprised the market and showed that the <a href="http://www.bloomberg.com/apps/news?pid=20601086&#38;sid=aEmfZ.hOxE1o&#38;refer=latin_america" target="_blank">Chilean       economy is surprisingly resistant</a> to a rapid deceleration,” Juan Pablo       Castro, an economist at <strong><a href="http://finance.google.com/finance?q=SAO:SANB3" target="_blank">Banco Santander SA</a></strong> in Santiago, told&#8230;</li></ul>]]></description>
			<content:encoded><![CDATA[<p>Existing Home Sales Down 3.1%; Chile’s 3Q GDP Beat Forecast; SunPower Finishes 18-Megawatt Plant; Cnooc Pushing to Develop More Oil Sites; Alpharma Gets Kinged; Xerox On Track; Oil Jumps 9%; </p>
<ul type="disc">
<li>Sales       of existing homes fell 3.1% in October, <a href="http://www.reuters.com/article/newsOne/idUSTRE4AN45720081124" target="_blank">the       lowest drop in four years</a>, <strong><em>Reuters</em></strong> reported. Over the past year, medium home prices also declined 11.3% to $183,300, the biggest percentage drop since the National Association of Realtors began keeping records in 1968.</li>
</ul>
<ul type="disc">
<li>Chile’s gross domestic product beat forecasts and grew 4.8% in the third quarter. Domestic demand was strong, as was energy output. “These figures surprised the market and showed that the <a href="http://www.bloomberg.com/apps/news?pid=20601086&amp;sid=aEmfZ.hOxE1o&amp;refer=latin_america" target="_blank">Chilean       economy is surprisingly resistant</a> to a rapid deceleration,” Juan Pablo       Castro, an economist at <strong><a href="http://finance.google.com/finance?q=SAO:SANB3" target="_blank">Banco Santander SA</a></strong> in Santiago, told <strong><em>Bloomberg</em></strong>. “Consumption is still growing at around 6 percent even though you’d expect to see the effects of inflation and interest-rate rises.”</li>
</ul>
<ul type="disc">
<li>Shares       of Solar power manufacturer <strong>SunPower Corp.</strong> (<a href="http://finance.google.com/finance?q=NASDAQ:SPWRA" target="_blank">SPWRA</a>) jumped       yesterday after the company announced it had <a href="http://money.cnn.com/news/newsfeeds/articles/prnewswire/200811240305PR_NEWS_USPR_____AQM003A.htm" target="_blank">completed       an 18-megawatt solar electric       power plant</a> in Badajoz, Spain. The plant’s SunPower Tracker follows the sun as it moves across the sky, increasing sunlight capture by up to 30% more than conventional fixed-tilt systems.</li>
</ul>
<ul type="disc">
<li>China       oil titan <strong>Cnooc Ltd.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3ACEO" target="_blank">CEO</a>) and       undisclosed partners may <a href="http://www.bloomberg.com/apps/news?pid=20601089&amp;sid=aiyOqQh6Qj5I&amp;refer=china" target="_blank">spend       up to $29 billion to develop deposits in the South China Sea</a>. The state-run oil company is making a big push to feed domestic energy demand as well as put its flag in an oil-rich aquatic area where its facing exploration competition from Vietnam and Indonesia, <strong><em>Bloomberg </em></strong>reported.</li>
</ul>
<ul type="disc">
<li><strong>Alpharma       Inc.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3AALO" target="_blank">ALO</a>)       yesterday (Monday) agreed to <strong>King Pharmaceuticals Inc.</strong>’s (<a href="http://finance.google.com/finance?q=NYSE%3AKG" target="_blank">KG</a>) $1.6 billion cash takeover offer. The deal values Alpharma at $37 a share – a 54% premium to the company’s closing price on Aug. 21, the last trading day before King’s initial $33-per-share bid.</li>
</ul>
<ul type="disc">
<li><strong>Xerox       Corp.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3AXRX" target="_blank">XRX</a>)       yesterday (Monday) said <a href="http://www.xerox.com/go/xrx/template/inv_rel_newsroom.jsp?app=Newsroom&amp;ed_name=NR_2008Nov24_InvestorConference&amp;format=article&amp;view=newsrelease&amp;Xcntry=USA&amp;Xlang=en_US" target="_blank">that       2009 profits are generally in line with analyst expectations</a> and that its strong contingent of repeat customers coupled with cost cuts will help it weather the economic downturn. The company, which last month said it plans to cut about 3,000 jobs, or 5% of its work force, expects 2009 profit to range between $1 a share to $1.25 a share.</li>
</ul>
<ul>
<li> The price of crude oil yesterday (Monday) rose $4.57 a barrel, or 9.15%, to settle at $54.50 a barrel on the New York Mercantile Exchange. Oil climbed more than $5 earlier in the day, reaching a session high of $55.30 a barrel on hopes that equity markets will continue to recover.</li>
</ul>
<p>Source: <a class="titleref" href="http://www.moneymorning.com/2008/11/25/global-investing-roundups-154/">Global Investing  Roundups, Tuesday, November 25th, 2008</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.contrarianprofits.com/articles/global-investing-roundups-tuesday-november-25th-2008/9064/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global Investing Roundups Friday, September 12th, 2008</title>
		<link>http://www.contrarianprofits.com/articles/global-investing-roundups-friday-september-12th-2008/5362</link>
		<comments>http://www.contrarianprofits.com/articles/global-investing-roundups-friday-september-12th-2008/5362#comments</comments>
		<pubDate>Fri, 12 Sep 2008 13:08:55 +0000</pubDate>
		<dc:creator>William Patalon III</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[International Investing]]></category>
		<category><![CDATA[ALO]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Banking Stocks]]></category>
		<category><![CDATA[Biotech Stocks]]></category>
		<category><![CDATA[Bmy]]></category>
		<category><![CDATA[CPB]]></category>
		<category><![CDATA[Crude Oil Prices]]></category>
		<category><![CDATA[DB]]></category>
		<category><![CDATA[ITMCL]]></category>
		<category><![CDATA[KG]]></category>
		<category><![CDATA[Nyt]]></category>
		<category><![CDATA[SRZ]]></category>
		<category><![CDATA[STD]]></category>
		<category><![CDATA[US stocks]]></category>
		<category><![CDATA[William Patalon III]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/articles/global-investing-roundups-friday-september-12th-2008/5362</guid>
		<description><![CDATA[<p>Slim Bites Into Big Apple Daily; Campbell’s Earnings Mmm, Mmm Good; King’s Alpharma Bid Heats Up; Conflicting Crude Trader Findings; WSJ: BAC to Buy Lehman; Bristol Doesn’t Budge; Sun Setting on Sunrise; Deutsche Bank Ready to Compete for Postbank</p>
<ul type="disc">
<li>Carlos       Slim, the Mexican billionaire <strong><em>Forbes</em></strong> ranks as the       second-richest man in the world, yesterday (Thursday) announced he       purchased a 6.4% stake in <strong>New York Times</strong> <strong>Co. </strong>(<a href="http://finance.google.com/finance?q=NYSE%3ANYT">NYT</a>). Slim       called the publisher of <strong><em>The New York Times</em></strong> an &#8220;<a href="http://www.bloomberg.com/apps/news?pid=20601086&#38;sid=atUoqmLRiR.8&#38;refer=latin_america">attractive       value</a>&#8221; due to the stock’s 20% loss so far this year, <strong><em>Bloomberg       News</em></strong> reported.</li>
</ul>
<ul type="disc">
<li><strong>Campbell       Soup Co.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3ACPB">CPB</a>) yesterday (Thursday) announced quarterly profit for its fiscal fourth quarter ended Aug. 3 increased 46% from the year ago period as the company increased prices to offset higher commodity costs. Campbell’s&#8230;</li></ul>]]></description>
			<content:encoded><![CDATA[<p>Slim Bites Into Big Apple Daily; Campbell’s Earnings Mmm, Mmm Good; King’s Alpharma Bid Heats Up; Conflicting Crude Trader Findings; WSJ: BAC to Buy Lehman; Bristol Doesn’t Budge; Sun Setting on Sunrise; Deutsche Bank Ready to Compete for Postbank</p>
<ul type="disc">
<li>Carlos       Slim, the Mexican billionaire <strong><em>Forbes</em></strong> ranks as the       second-richest man in the world, yesterday (Thursday) announced he       purchased a 6.4% stake in <strong>New York Times</strong> <strong>Co. </strong>(<a href="http://finance.google.com/finance?q=NYSE%3ANYT">NYT</a>). Slim       called the publisher of <strong><em>The New York Times</em></strong> an &#8220;<a href="http://www.bloomberg.com/apps/news?pid=20601086&amp;sid=atUoqmLRiR.8&amp;refer=latin_america">attractive       value</a>&#8221; due to the stock’s 20% loss so far this year, <strong><em>Bloomberg       News</em></strong> reported.</li>
</ul>
<ul type="disc">
<li><strong>Campbell       Soup Co.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3ACPB">CPB</a>) yesterday (Thursday) announced quarterly profit for its fiscal fourth quarter ended Aug. 3 increased 46% from the year ago period as the company increased prices to offset higher commodity costs. Campbell’s reported net earnings of $89 million, or $0.24 per share, compared to $61 million, or $0.16 per share for the prior year <a href="http://investor.shareholder.com/campbell/releasedetail.cfm?ReleaseID=333834">in       a company statement</a>.</li>
</ul>
<ul type="disc">
<li><strong>King       Pharmaceuticals Inc.</strong> (<a href="http://finance.google.com/finance?q=kg">KG</a>)       upped its takeover offer for <strong>Alpharma Inc.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3AALO">ALO</a>) yesterday (Thursday) to almost $1.6 billion. King raised its offer to $37 per share from its initial bid of $33 per share and said it plans <a href="http://www.reuters.com/article/innovationNews/idUSN1140684520080911">to       take the new offer directly to shareholders</a>, <strong><em>Reuters</em></strong> reported.</li>
</ul>
<ul>
<li>According to a report published yesterday (Thursday) by the Commodity Futures Trading Commission, commodity index traders only accounted for 13% of crude oil futures trading on the New York Mercantile Exchange in the first half of 2008, <strong><em>Bloomberg News</em></strong> reported. &#8220;<a href="http://www.bloomberg.com/apps/news?pid=20601087&amp;sid=aIA.U.WwSJsY&amp;refer=home">At first glance the numbers seem inconsistent with the allegations that swaps traders and index traders are driving up the price of oil</a>,&#8221; said Robert  Webb, a finance professor at the University of Virginia.</li>
</ul>
<ul type="disc">
<li><strong>Bank       of America Corp.</strong> (<a href="http://finance.google.com/finance?q=bac&amp;hl=en">BAC</a>) <a href="http://online.wsj.com/article/SB122116292232524671.html?mod=hpp_us_whats_news">is       in talks to buy</a> <strong>Lehman Brothers Holdings Inc.</strong> (<a href="http://finance.google.com/finance?q=leh&amp;hl=en">LEH</a>), the <strong><em>Wall       Street Journal </em></strong>reported, citing an unnamed source. Sources say <strong>Goldman       Sachs Group Inc</strong>. (<a href="http://finance.google.com/finance?q=gs&amp;hl=en">GS</a>), also       thought to be interested, will not takeover the beleaguered firm.</li>
</ul>
<ul type="disc">
<li><strong>Bristol-Myers Squibb Co.</strong> (<a href="http://finance.google.com/finance?q=NYSE%3ABMY">BMY</a>) yesterday       (Thursday) reiterated its $60 per share offer for <strong>ImClone Systems Inc.</strong> (<a href="http://finance.google.com/finance?q=NASDAQ%3AIMCL">IMCL</a>),       even though the biotechnology company said earlier this week that a secret       suitor is offering $10 a share more.</li>
</ul>
<ul type="disc">
<li>Shares       of <strong>Sunrise Senior Living Inc. </strong>(<a href="http://finance.google.com/finance?q=NYSE%3ASRZ">SRZ</a>) yesterday (Thursday) reported a $31.8 million second-quarter loss. The company’s shares fell $2.56, or 13.5%, to close at $16.36 after falling as low as $16.22 earlier in the day. On Wednesday, the stock fell $1.82, or 8.8%.</li>
</ul>
<ul type="disc">
<li><strong>Deutsche       Bank AG</strong> (<a href="http://finance.google.com/finance?q=NYSE%3ADB">DB</a>)       will today (Friday) <a href="http://www.iht.com/articles/2008/09/11/business/post.php">announce       the purchase of a controlling stake</a> in <strong>Postbank</strong>, a profitable       German institution worth about $14.6 billion, the <strong><em>International       Herald Tribune</em></strong> reported. This opens up the door for a potential       bidding war with Banco Santander SA (ADR: <a href="http://finance.google.com/finance?q=NYSE%3ASTD">STD</a>), which said       Thursday that it wanted to negotiate the purchase of all of Postbank.</li>
</ul>
<p>Source: <a href="http://www.moneymorning.com/2008/09/12/global-investing-news/">Global Investing Roundups Friday, September 12th, 2008</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.contrarianprofits.com/articles/global-investing-roundups-friday-september-12th-2008/5362/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1.092 seconds -->
